UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

Date of report (Date of earliest event reported): December 6, 2023

ASTRONOVA, INC.

(Exact name of registrant as specified in its charter)


Rhode Island
0-13200
05-0318215

(State or other jurisdiction

of incorporation)

(Commission

File Number)

(I.R.S. Employer

Identification No.)

 


600 East Greenwich Avenue
West Warwick, RI 02893
(Address of principal executive offices) (Zip Code)

(401) 828-4000

Registrant’s telephone number, including area code

Not applicable

(Former name or former address, if changed since last report.)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class

 

Trading

Symbol(s)

 

Name of Each Exchange

on which Registered

Common Stock, $0.05 Par Value
  ALOT
  NASDAQ Global Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐



Item 2.02        Results of Operations and Financial Condition.
On December 6, 2023, we issued a press release reporting the financial results for our fiscal 2024 third quarter ended October 28, 2023.  A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
The information contained in Item 2.02 of this report and Exhibit 99.1 attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.
Item 9.01       Financial Statement and Exhibits.
(d)      Exhibits

Exhibit No.
Exhibit
 
 
104
Cover Page Interactive Data File (embedded within the Inline XBRL document)

2


SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
 
ASTRONOVA, INC.
 
 
Dated:  December 6, 2023
By:
/s/  David S. Smith
 
 
David S. Smith
 
 
Vice President, Chief Financial Officer and Treasurer



3
Exhibit 99.1

AstroNova Reports Fiscal 2024 Third-Quarter Financial Results

Company to Host Conference Call at 9:00 a.m. ET Today

Third-Quarter Fiscal 2024 Financial Highlights

  • Revenue of $37.5 million, down 4.7% year over year (YoY)
  • Gross margin of 39.4%, up 770 basis points YoY
  • Operating margin of 12.3%, up 890 basis points YoY
  • Diluted EPS of $0.37, up 825% YoY
  • Record quarterly Adjusted EBITDA of $5.7 million, or 15% of revenue, up 135% YoY

WEST WARWICK, R.I.--(BUSINESS WIRE)--December 6, 2023--AstroNova, Inc. (Nasdaq: ALOT), a global leader in data visualization technologies, today reported financial results for the fiscal 2024 third quarter ended October 28, 2023. GAAP diluted earnings per share were $0.37 compared with $0.04 per diluted share in the year-earlier period. Last year’s third-quarter GAAP results included transaction costs of $0.07 per diluted share associated with the acquisition of Astro Machine, Inc. at the beginning of that quarter. This is the first quarter in which Astro Machine’s results are included in all comparisons with the prior-year periods.

Commentary from Greg Woods, President and Chief Executive Officer

“We delivered significantly improved earnings performance in the third quarter despite an 11% YoY revenue decline in our Product Identification (PI) segment. This decline was largely driven by sidelined printers that were affected by the previously discussed ink quality issues from one of our suppliers and, to a lesser degree, the exit of some low margin printers last quarter from our portfolio. As our retrofitting program continues, the supplies revenue from these printers is expected to recover over the coming quarters.

“Our strong profit and cash flow improvement was fueled by a combination of favorable product mix in both segments, continued focus on expense control and the benefits of the PI segment realignment last quarter.

“Our PI segment generated a 62% increase in third-quarter operating profit as we focus on more profitable products, transition more printer manufacturing from Asia and West Warwick to the Astro Machine plant in Illinois, exit low margin or low volume label printer models, consolidate international sales and distribution facilities, and streamline our global channel partner network.

“Our Test and Measurement segment maintained its strong performance in the third quarter, bolstered by the ongoing post-pandemic rebound of the commercial aviation market. Segment revenue increased 16%, while segment operating profit was up 50%.

“The recently completed strategic restructuring has significantly improved the cost structure and margin profile of the business and we expect both segments to perform in line with these results again in the fourth quarter.”


Third-Quarter Fiscal 2024 Income Statement Summary

($ in thousands, except per share data)


Q3 2024


Q3 2023


YoY

Revenue


$37,549


$39,405


(5%)

Gross Profit


$14,779


$12,482


18%

Gross Margin


39.4%


31.7%


770 bps

Operating Expenses


$10,161


$11,136


(9%)

Operating Income


$4,618


$1,346


243%

Operating Margin


12.3%


3.4%


890 bps

Net Income


$2,752


$289


870%

Net Income Per Diluted Share


$0.37


$0.04


825%

Third-Quarter Fiscal 2024 Financial Summary

Total revenue was $37.5 million, down 4.7% from the year-earlier period. The decrease reflected lower revenue in the PI segment, due primarily to lower supplies revenue from printers impacted by the defective ink from one of our larger suppliers and, in part, to the Company’s product rationalization initiatives. The decline in PI was partly offset by higher revenue from the Test & Measurement segment.

Hardware revenue was $12.9 million, a 7.7% increase from the prior-year period. Supplies revenue was $20.0 million, down 13% from the same period in fiscal 2023. Revenue from Service/Other was $4.7 million, up 4.4% from the comparable period last year.

Gross profit totaled $14.8 million, or 39.4% of revenue, compared with gross profit of $12.5 million, or 31.7% of revenue, in the year-earlier period. The increase was attributable primarily to favorable product mix, lower manufacturing variances and reduced period costs and the Company’s strategic realignment of its PI segment.

Operating expenses were $10.2 million, a decrease of 8.8% from $11.1 million in the same period last year, driven primarily by lower general and administrative expenses.

Operating income increased to $4.6 million, or 12.3% of revenue, from $1.3 million, or 3.4% of revenue, in the same period of fiscal 2023.

The Company reported net income of $2.8 million, or $0.37 per diluted share, compared with $289,000, or $0.04 per diluted share, a year earlier. Net income under Generally Accepted Accounting Principles (GAAP) for the third quarter of fiscal 2023 included transaction costs of $540,000, or $0.07 per diluted share, associated with the August 2022 acquisition of Astro Machine. On a non-GAAP basis, net income for the third quarter of fiscal 2023 was $829,000, or $0.11 per diluted share.

Earnings before interest, taxes, depreciation, and amortization (EBITDA) was $5.3 million for the third quarter of fiscal 2024, compared with $2.0 million for the same period in fiscal 2023. Excluding the Astro Machine transaction costs, EBITDA for the third quarter of fiscal 2023 was $2.7 million.


Adjusted EBITDA, which the Company defines as earnings before interest, taxes, depreciation, amortization and share-based compensation, was $5.7 million, or 15% of revenue, in the third quarter of fiscal 2024, compared with $2.4 million, or 6% of revenue, in the same period of fiscal 2023. Excluding transaction costs, Adjusted EBITDA for the third quarter of fiscal 2023 was $3.1 million.

Bookings for the third quarter of fiscal 2024 increased 1% to $35.5 million from $35.0 million in the third quarter of fiscal 2023.

Backlog as of October 28, 2023 decreased 20% to $31.2 million from $39.3 million as of October 29, 2022.

Third-Quarter Fiscal 2024 Operating Segment Results

Product Identification

PI segment revenue was $26.5 million in the third quarter of fiscal 2024, down 11.2% from $29.9 million in the same period a year earlier. Segment operating profit was $4.8 million, or 18.1% of revenue, compared with $3.0 million, or 9.9% of revenue, in the same period of fiscal 2023.

Test & Measurement

Test & Measurement segment revenue increased 15.5% to $11.0 million in the third quarter of fiscal 2024 from $9.5 million in the same period last year. Segment operating profit was $2.6 million, or 23.2% of revenue, compared with $1.7 million, or 18.0% of revenue, a year earlier.

Earnings Conference Call Information

AstroNova will discuss the third-quarter fiscal 2024 financial results in an investor conference call at 9:00 a.m. ET today. To access the conference call, please dial (833) 470-1428 (U.S. and Canada) or (404) 975-4839 (International) approximately 10 minutes prior to the start time and enter access code 519743. A real-time and an archived audio webcast of the call will be available through the “Investors” section of the AstroNova website, https://investors.astronovainc.com.

Use of Non-GAAP Financial Measures

In addition to financial measures prepared in accordance with generally accepted accounting principles (GAAP), this news release contains the non-GAAP financial measures EBITDA, Adjusted EBITDA, non-GAAP net income and non-GAAP net income per diluted share.

AstroNova believes that the inclusion of these non-GAAP financial measures helps investors gain a meaningful understanding of changes in the Company’s core operating results and can help investors who wish to make comparisons between AstroNova and other companies on both a GAAP and a non-GAAP basis. AstroNova’s management uses these non-GAAP financial measures, in addition to GAAP financial measures, as the basis for measuring its core operating performance and comparing such performance to that of prior periods and to the performance of its competitors. These measures are also used by the Company’s management to assist with their financial and operating decision-making. Please refer to the financial reconciliation tables included in this news release for a reconciliation of GAAP measures to the most directly comparable non-GAAP measures for the three and nine months ended October 28, 2023 and October 29, 2022.

About AstroNova

AstroNova (Nasdaq: ALOT), a global leader in data visualization technologies since 1969, designs, manufactures, distributes, and services a broad range of products that acquire, store, analyze, and present data in multiple formats.


The Product Identification segment provides a wide array of digital, end-to-end product marking and identification solutions, including hardware, software, and supplies for OEMs, commercial printers, and brand owners. The Test and Measurement segment provides products designed for airborne printing solutions, avionics, and data acquisition. Our aerospace products include flight deck printing solutions, networking hardware, and specialized aerospace-grade supplies. Our data acquisition systems are used in research and development, flight testing, missile and rocket telemetry production monitoring, power, and maintenance applications.

AstroNova is a member of the Russell Microcap® Index and the LD Micro Index (INDEXNYSEGIS: LDMICRO). Additional information is available by visiting https://astronovainc.com/.

Forward-Looking Statements

Information included in this news release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are not statements of historical fact, but rather reflect our current expectations concerning future events and results. These statements may include the use of the words “believes,” “expects,” “intends,” “plans,” “anticipates,” “likely,” “continues,” “may,” “will,” and similar expressions to identify forward-looking statements. Such forward-looking statements, including those concerning the Company’s anticipated performance, involve risks, uncertainties and other factors, some of which are beyond our control, which may cause our actual results, performance or achievements to be materially different from those expressed or implied by such forward-looking statements. These risks, uncertainties and factors include, but are not limited to, (i) the risk that we may not be able to realize the expected synergies from our acquisition of Astro Machine, (ii) the risk that apparent improvements in the Aerospace and Defense sectors may not continue and (iii) those factors set forth in the Company’s Annual Report on Form 10-K for the fiscal year ended January 31, 2023 and subsequent filings AstroNova makes with the Securities and Exchange Commission. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. The reader is cautioned not to unduly rely on such forward-looking statements when evaluating the information presented in this news release.


ASTRONOVA, INC.

Condensed Consolidated Statements of Income (Loss)

In Thousands Except for Per Share Data

(Unaudited)









 


Three Months Ended


Nine Months Ended



October 28, 2023


October 29, 2022


October 28, 2023


October 29, 2022

Net Revenue

$

37,549


$

39,405


$

108,493


$

102,674

Cost of Revenue

 

22,770


 

26,923


 

71,618


 

68,080

Gross Profit

 

14,779


 

12,482


 

36,875


 

34,594

Total Gross Profit Margin

 

39.4%


 

31.7%


 

34.0%


 

33.7%

Operating Expenses:







Selling & Marketing

 

5,744


 

5,908


 

18,451


 

17,771

Research & Development

 

1,683


 

1,903


 

5,028


 

5,021

General & Administrative

 

2,734


 

3,325


 

8,514


 

8,456

Total Operating Expenses

 

10,161


 

11,136


 

31,993


 

31,248

Operating Income

 

4,618


 

1,346


 

4,882


 

3,346

Total Operating Margin

 

12.3%


 

3.4%


 

4.5%


 

3.3%

Other Expense, net

 

917


 

955


 

2,161


 

1,665

Income Before Taxes

 

3,701


 

391


 

2,721


 

1,681

Income Tax Provision

 

949


 

102


 

738


 

383

Net Income

$

2,752


$

289


$

1,983


$

1,298

Net Income per Common Share - Basic

$

0.37


$

0.04


$

0.27


$

0.18

Net Income per Common Share - Diluted

$

0.37


$

0.04


$

0.27


$

0.18









 
Weighted Average Number of Common Shares - Basic

 

7,428


 

7,324


 

7,407


 

7,299

Weighted Average Number of Common Shares - Diluted

 

7,485


 

7,485


 

7,477


 

7,363













 

ASTRONOVA, INC.

Consolidated Balance Sheets

In Thousands

(Unaudited)





 


October 28, 2023


January 31, 2023

ASSETS



CURRENT ASSETS



Cash and Cash Equivalents

$

4,827

 


$

3,946

 

Accounts Receivable, net

 

21,999

 


 

21,598

 

Inventories, net

 

47,005

 


 

51,324

 

Prepaid Expenses and Other Current Assets

 

3,056

 


 

2,894

 

Total Current Assets

 

76,887

 


 

79,762

 

PROPERTY, PLANT AND EQUIPMENT

 

56,572

 


 

55,394

 

Less Accumulated Depreciation

 

(42,320

)


 

(41,106

)

Property, Plant and Equipment, net

 

14,252

 


 

14,288

 

OTHER ASSETS



Intangible Assets, net

 

19,420

 


 

21,232

 

Goodwill

 

14,440

 


 

14,658

 

Deferred Tax Assets

 

6,903

 


 

6,907

 

Right of Use Asset

 

650

 


 

794

 

Other Assets

 

1,651

 


 

1,566

 

TOTAL ASSETS

$

134,203

 


$

139,207

 

LIABILITIES AND SHAREHOLDERS’ EQUITY



CURRENT LIABILITIES



Accounts Payable

$

4,893

 


$

8,479

 

Accrued Compensation

 

3,256

 


 

2,750

 

Other Liabilities and Accrued Expenses

 

4,410

 


 

3,308

 

Revolving Line of Credit

 

14,900

 


 

15,900

 

Current Portion of Long-Term Debt

 

2,700

 


 

2,100

 

Current Portion of Royalty Obligation

 

1,500

 


 

1,725

 

Current Liability – Excess Royalty Payment Due

 

542

 


 

562

 

Income Taxes Payable

 

56

 


 

786

 

Deferred Revenue

 

1,441

 


 

1,888

 

Total Current Liabilities

 

33,698

 


 

37,498

 

NON-CURRENT LIABILITIES



Long-Term Debt, net of current portion

 

10,039

 


 

12,040

 

Royalty Obligation, net of current portion

 

2,476

 


 

3,415

 

Lease Liability, net of current portion

 

459

 


 

555

 

Income Taxes Payable

 

491

 


 

491

 

Deferred Revenue

 

-

 


 

674

 

Deferred Tax Liabilities

 

152

 


 

167

 

TOTAL LIABILITIES

 

47,315

 


 

54,840

 

SHAREHOLDERS’ EQUITY



Common Stock

 

540

 


 

534

 

Additional Paid-in Capital

 

62,340

 


 

61,131

 

Retained Earnings

 

61,158

 


 

59,175

 

Treasury Stock

 

(34,588

)


 

(34,235

)

Accumulated Other Comprehensive Loss, net of tax

 

(2,562

)


 

(2,238

)

TOTAL SHAREHOLDERS’ EQUITY

 

86,888

 


 

84,367

 

TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY

$

134,203

 


$

139,207

 









 

ASTRONOVA, INC.

Revenue and Segment Operating Profit

In Thousands

(Unaudited)

















 


Revenue


Segment Operating Profit


Revenue


Segment Operating Profit



Three Months Ended


Three Months Ended


Nine Months Ended


Nine Months Ended



October 28,
2023


October 29,
2022


October 28,
2023


October 29,
2022


October 28,
2023


October 29,
2022


October 28,
2023


October 29,
2022

Product Identification

$

26,543


$

29,879


$

4,794

 


$

2,960

 


$

77,416


$

74,985


$

6,848

 


$

6,019

 

Test & Measurement

 

11,006


 

9,526


 

2,558

 


 

1,711

 


 

31,077


 

27,689


 

6,548

 


 

5,783

 

Total

$

37,549


$

39,405


 

7,352

 


 

4,671

 


$

108,493


$

102,674


 

13,396

 


 

11,802

 

Corporate Expenses




 

2,734

 


 

3,325

 






 

8,514

 


 

8,456

 

Operating Income




 

4,618

 


 

1,346

 






 

4,882

 


 

3,346

 

Other Income (Expense), net




 

(917

)


 

(955

)






 

(2,161

)


 

(1,665

)

Income Before Income Taxes




 

3,701

 


 

391

 






 

2,721

 


 

1,681

 

Income Tax Provision




 

949

 


 

102

 






 

738

 


 

383

 

Net Income




$

2,752

 


$

289

 






$

1,983

 


$

1,298

 

























 

ASTRONOVA, INC.

Reconciliation of GAAP to Non-GAAP Results

In Thousands Except for Per Share Data

(Unaudited)










 



Three Months Ended


Nine Months Ended




October 28, 2023


October 29, 2022


October 28, 2023


October 29, 2022










 
GAAP Revenues

$

37,549

 


$

39,405

 


$

108,493

 


$

102,674

 

Non-GAAP Revenues

$

37,549

 


$

39,405

 


$

108,493

 


$

102,674

 










 
GAAP Cost of Revenues

$

22,770

 


$

26,923

 


$

71,618

 


$

68,080

 


Restructuring Charges

 

-

 


 

-

 


 

2,096

 


 

-

 


Product Retrofit Costs

 

-

 


 

-

 


 

852

 


 

-

 

Non-GAAP Cost of Revenues

$

22,770

 


$

26,923

 


$

68,670

 


$

68,080

 










 
GAAP Gross Profit

$

14,779

 


$

12,482

 


$

36,875

 


$

34,594

 


Restructuring Charges

 

-

 


 

-

 


 

2,096

 


 

-

 


Product Retrofit Costs

-

 


-

 


 

852

 


-

 

Non-GAAP Gross Profit

$

14,779

 


$

12,482

 


$

39,823

 


$

34,594

 










 
GAAP Operating Expenses

$

10,161

 


$

11,136

 


$

31,993

 


$

31,248

 


Transaction Costs

 

-

 


 

(717

)


 

-

 


 

(717

)


Restructuring Charges

 

-

 


 

-

 


 

(555

)


 

-

 

Non-GAAP Operating Expenses

$

10,161

 


$

10,419

 


$

31,438

 


$

30,531

 










 
GAAP Operating Income

$

4,618

 


$

1,346

 


$

4,882

 


$

3,346

 


Transaction Costs

 

-

 


 

717

 


 

-

 


 

717

 


Restructuring Charges

 

-

 


 

-

 


 

2,651

 


 

-

 


Product Retrofit Costs

 

-

 


 

-

 


 

852

 


 

-

 

Non-GAAP Operating Income

$

4,618

 


$

2,063

 


$

8,385

 


$

4,063

 










 
GAAP Other Income/(Expense)

$

(917

)


$

(955

)


$

(2,161

)


$

(1,665

)

Non-GAAP Other Income/(Expense)

$

(917

)


$

(955

)


$

(2,161

)


$

(1,665

)










 
GAAP Income Tax Expense

$

949

 


$

102

 


$

738

 


$

383

 


Tax Adjustments of Non-GAAP Adjustments

 

-

 


 

177

 


 

797

 


 

177

 

Non-GAAP Income Tax Expense

$

949

 


$

279

 


$

1,535

 


$

560

 










 
GAAP Net Income

$

2,752

 


$

289

 


$

1,983

 


$

1,298

 


Transaction Costs

 

-

 


 

540

 


 

-

 


 

540

 


Restructuring Charges

 

-

 


 

-

 


 

2,048

 


 

-

 


Product Retrofit Costs

 

-

 


 

-

 


 

658

 


 

-

 

Non-GAAP Net Income

$

2,752

 


$

829

 


$

4,689

 


$

1,838

 










 
GAAP Diluted Earnings Per Share

$

0.37

 


$

0.04

 


$

0.27

 


$

0.18

 


Transaction Costs

 

-

 


 

-

 


 

-

 


 

0.07

 


Restructuring Charges

 

-

 


 

-

 


 

0.28

 


 

-

 


Product Retrofit Costs

 

-

 


 

-

 


 

0.09

 


 

-

 

Non-GAAP Diluted Earnings Per Share

$

0.37

 


$

0.04

 


$

0.63

 


$

0.25

 















ASTRONOVA, INC.

Reconciliation of Net Income to EBITDA

Amounts In Thousands

(Unaudited)









 


Three Months Ended
Nine Months Ended


October 28, 2023
October 29, 2022
October 28, 2023
October 29, 2022








 

GAAP Net Income


$

2,752


$

289


$

1,983


$

1,298

Interest Expense


 

630


 

701


 

1,919


 

1,086

Income Tax Expense


 

949


 

102


 

738


 

383

Depreciation/Amortization


 

1,014


 

915


 

3,158


 

2,737

EBITDA


$

5,345


$

2,007


$

7,798


$

5,504

Transaction Costs


 

-


 

540


 

-


 

540

Restructuring Charges


 

-


 

-


 

2,048


 

-

Product Retrofit Costs


 

-


 

-


 

658


 

-

Income Tax Expense - Transaction Costs


 

-


 

176


 

-


 

176

Income Tax Expense - Restructuring Charges


 

-


 

-


 

603


 

-

Income Tax Expense - Product Retrofit Costs


 

-


 

-


 

194


 

-

EBITDA Less Restructuring & Retrofit Items


$

5,345


$

2,723


$

11,301


$

6,220













 

ASTRONOVA, INC.

Reconciliation of Net Income to Adjusted EBITDA

Amounts In Thousands

(Unaudited)









 


Three Months Ended


Nine Months Ended



October 28, 2023


October 29, 2022


October 28, 2023


October 29, 2022









 
GAAP Net Income

$

2,752


$

289


$

1,983


$

1,298

Interest Expense

 

630


 

701


 

1,919


 

1,086

Income Tax Expense

 

949


 

102


 

738


 

383

Depreciation/Amortization

 

1,014


 

915


 

3,158


 

2,737

Share-Based Compensation

 

311


 

405


 

1,065


 

977

Adjusted EBITDA

$

5,656


$

2,412


$

8,863


$

6,481

Transaction Costs

 

-


 

540


 

-


 

540

Restructuring Charges

 

-


 

-


 

2,048


 

-

Product Retrofit Costs

 

-


 

-


 

658


 

-

Income Tax Expense - Transaction Costs

-


 

176


 

-


 

176

Income Tax Expense - Restructuring Charges

-


 

-


 

603


 

-

Income Tax Expense - Product Retrofit Costs

-


 

-


 

194


 

-

Adjusted EBITDA Less Restructuring & Retrofit Items

$

5,656


$

3,128


$

12,366


$

7,197













 

ASTRONOVA, INC.

Reconciliation of Segment GAAP to Non-GAAP Operating Income

Amounts In Thousands

(Unaudited)

























 


Three Months Ended


Nine Months Ended



October 28, 2023


October 29, 2022


October 28, 2023


October 29, 2022



Product

Identification


Test &

Measurement


Total


Product

Identification


Test &

Measurement


Total


Product

Identification


Test &

Measurement


Total


Product

Identification


Test &

Measurement


Total

























 

GAAP - Segment Operating Profit


$

4,794


$

2,558


$

7,352


$

2,960


$

1,711


$

4,671


$

6,848


$

6,548


$

13,396


$

6,019


$

5,783


$

11,802

























 

Restructuring Charges


 

-


 

-


 

-


 

-


 

-


 

-


 

2,568


 

-


 

2,568


 

-


 

-


 

-

























 

Product Retrofit Costs


 

-


 

-


 

-


 

-


 

-


 

-


 

852


 

-


 

852


 

-


 

-


 

-

























 

Non-GAAP - Segment Operating Profit


$

4,794


$

2,558


$

7,352


$

2,960


$

1,711


$

4,671


$

10,268


$

6,548


$

16,816


$

6,019


$

5,783


$

11,802

 

Contacts

Scott Solomon
Senior Vice President
Sharon Merrill Advisors
(857) 383-2409
ALOT@investorrelations.com

v3.23.3
Document and Entity Information
Dec. 06, 2023
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Dec. 06, 2023
Entity Registrant Name AstroNova, Inc.
Entity Incorporation, State or Country Code RI
Entity File Number 0-13200
Entity Tax Identification Number 05-0318215
Entity Address, Address Line One 600 East Greenwich Avenue
Entity Address, City or Town West Warwick
Entity Address, State or Province RI
Entity Address, Postal Zip Code 02893
City Area Code 401
Local Phone Number 828-4000
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company false
Entity Central Index Key 0000008146
Title of 12(b) Security Common Stock, $0.05 Par Value
Trading Symbol ALOT
Security Exchange Name NASDAQ

AstroNova (NASDAQ:ALOT)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more AstroNova Charts.
AstroNova (NASDAQ:ALOT)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more AstroNova Charts.